预防肿瘤学
上QQ阅读APP看书,第一时间看更新

参考文献

[1]孔灵芝.中国慢性非传染性疾病防治的策略调整与实践.中华预防医学杂志,2010,44(1):11-13.
[2]世界卫生组织. 2013—2020年预防控制非传染性疾病全球行动计划. 2013年5月召开的第66届世界卫生大会通过WHA66.10号决议批准.参见:www. who. int/ncd.
[3]World Cancer Research Fund/American Institute for Cancer Research.食物、营养、身体活动和癌症预防.陈君石,译.北京:中国协和医科大学出版社,2008.
[4]World Cancer Research Fund/American Institute for Cancer Research.食物、营养与癌症预防.陈君石,闻芝梅,译.上海:上海医科大学出版社,1997.
[5]Advisory Committee on Cancer Control,National Cancer Institute of Canada:Bridging research to action:a framework and decision-making process for cancer control. Can Med Assoc J,1994,151:1141-1146.
[6]American Cancer Society. Cancer Facts&Figures 2008. American Cancer Society,Atlanta:2013.
[7]Bao PP,Zheng Y,Wang CF,et al. Time trends and characteristics of childhood cancer among children age 0~14 in Shanghai. Pediatr Blood Cancer,2009,53:13-16.
[8]Behringer B,Lofton S,Knight ML. Models for local implementation of comprehensive cancer control:meeting local cancer control needs through community collaboration. Cancer Causes&Control,2010,21(12):1995-2004.
[9]Blackburn EH,Tlsty TD,Lippman SM. Unprecedented Opportunities and Promise for Cancer Prevention Research. Cancer Prev Res,2010,3(4):394-402.
[10]Bosetti C,Bertuccio P,Malvezzi M,et al. Cancer mortality in Europe,2005-2009,and an overview of trends since 1980. Annals of Oncology,2013,24(10):2657-2671.
[11]Boyle P and Bernard Levin B(Edited). World cancer report. IARC Lyon,France,2008.
[12]Boyle P,Anderson BO,Anderson LC,et al. Need for global action for cancer control. Ann Oncol 2008,19(9):1519-1521.
[13]Bray F,Jemal A,Grey N,et al:Global cancer transitions according to the Human Development Index (2008-2030):a population-based study. Lancet Oncol,2012,13:790-801.
[14]Bray F,Moller B. Predicting the future burden of cancer. Nat Rev Cancer,2006,6:63-74.
[15]Bray F,Ren JS,Masuyer E,et al. Global estimates of cancer prevalence for 27 sites in the adult population in 2008. Int J Cancer,2013,132(5):1133-1145.
[16]Brewster DH,Coebergh JW,Storm HH. Population-based cancer registries:the invisible key to cancer control. Lancet Oncol,2005,6:193-195.
[17]Cameron AJ,Brown KS,Cohen RS,et al. Critique of the National Cancer Institute of Canada's framework for cancer control. Cancer Prev. Control,1997,1:361-365.
[18]Cancer Control PLANET:Find Programme Partners in Cancer Control and Find Research Partners in Cancer Control(Step 2). Cancer Prev Res,2008,499-502.
[19]Castro C,Bosetti C,Malvezzi M,et al. Patterns and trends in esophageal cancer mortality and incidence in Europe(1980-2011)and predictions to 2015. Ann Oncol,2014,25(1):283-290.
[20]CDC. Framework for program evaluation in public health. Atlanta,GA:MMWR,1999,48(NoRR-11):1-40.
[21]CDC. Guidance for Comprehensive Cancer Control Planning-Volume 1:Guidelines and Volume 2:Tools. Division of Cancer Prevention and Control,US Centres for Disease Control and Prevention,Atlanta,2002.
[22]Doll R,Peto R. The causes of cancer:quantitative estimates of avoidable risks of cancer in the United States today. J Natl Cancer Inst,1981,66:1191-1308.
[23]Dong ZW,Qian YL,Wang GQ,et al. Evaluation of early diagnosis and treatment of cancer. Chin J Oncol,2012,34:637-640.
[24]Engstrom PF. Cancer prevention and control priorities for the year 2000:a commentary. Cancer(Phila.),74:1433-1437,1994.
[25]Engstrom PF. A New Era for Cancer Prevention and Control Research. Cancer Epidemiology,Biomarkers&Prevention,1999,(8):955-956.
[26]Eriksen M,Mackay J,Ross H. The Tobacco Atlas,4th ed. Atlanta,GA:American Cancer Society,World Lung Foundation,2012. Available at:http:/ /www. tobaccoatlas. org/events/un_ncd_summit2011/ political_declaration_en. pdf).
[27]Ferlay J,Shin HR,Bray F,et al. Estimates of worldwide burden of cancer in 2008:GLOBOCAN 2008. Int J Cancer,2010,127:2893-2917.
[28]Ferlay J,Soerjomataram I,Ervik M,et al:GLOBOCAN 2012 v1.0,Cancer Incidence and Mortality Worldwide:IARC Cancer Base No. 11. Lyon:IARC,2013. Available at:http:/ /globocan. iarc. fr.
[29]Fifty-eighth World Health Assembly. Resolution WHA58.22,May 25 2005. Cancer prevention and control. Geneva:World Health Organization 2005.
[30]Flora SD and Bonanni P. The prevention of infection-associated cancers. Carcinogenesis,2011,32(6):787-795.
[31]Forman D,Bray F,Brewster DH et al(Eds). Cancer Incidence in Five Continents,Vol. X[electronic version]. Lyon:IARC,2013. Available at http:/ /ci5. iarc. fr.
[32]Given LS,Hohman K,Graaf KL,et al. From planning to implementation to outcomes:comprehensive cancer control implementation building blocks. Cancer Causes&Control,2010,(21):1987-1994.
[33]Global Initiative for Cancer Registry Development in Low-and Middle-Income Countries. Available at:http:/ /gicr. iarc. fr/.
[34]Glynn T,Seffrin JR,Brawley OW,et al. The globalization of tobacco use:21 challenges for the 21st century. CA Cancer J Clin,2010,60:50-61.
[35]Goodman GE. Assessing Toxicity in Cancer Chemoprevention Trials:The Other Side of the Coin. Cancer Prev Res,2008,1:499-502.
[36]Greenwald P,Kramer BS and Weed DL(Eds):Cancer Prevention and Control. Marcel Dekker,Inc.,New York,1995.
[37]Hanna TP and Kangole ACT. Cancer control in developing countries:using health data and health services research to measure and improve access,quality and efficiency. BMC Int Health Hum Rights,10:24,2010. http:/ /dx. doi. org/10.1186/1472-698X-10-24.
[38]Harrop JP,Nelson DE,Kuratani DG,et al. Translating cancer prevention and control research into the community setting:workforce implications. J Cancer Educ,2012,27 Suppl 2:S157-S164.
[39]Hiatt RA,Rimer BK. A new strategy for cancer control research. Cancer Epidemiol Biomark Prev,1999,8:957-964.
[40]Ho MG,Ma S,Chai W,et al:Smoking among rural and urban young women in China. Tob Control,2010,19:13-18.
[41]IARC:IARC Handbooks of Cancer Prevention,Volume 8,Fruits and vegetables. Lyon,France:International Agency for Research on Cancer,2003.
[42]IARC. IARC Handbooks of Cancer Prevention,Vol. 14:Tobacco Control:Effectiveness of Tax and Price Policies for Tobacco Control. Lyon:IARC,2011.
[43]IARC. IARC Handbooks of Cancer Prevention,Volume 6,Weight control and physical activity. Lyon,France:International Agency for Research on Cancer,2002.
[44]IARC. Vitamin D and Cancer. IARC Working Group Reports Vol. 5,International Agency for Research on Cancer,Lyon,France,2008.
[45]Sloan FA,Gelband H. Cancer control opportunities in low-and middle-income countries. IOM,Washington,DC:National Academies Press,2007. Available from:www. nap. edu.
[46]IOM(Institute of Medicine). Delivering affordable cancer care in the 21st century:Workshop summary. Washington,DC:The National Academies Press,2013.
[47]Jemal A,Simard EP,Dorell C,et al. Annual report to the nation on the status of Cancer,1975-2009,featuring the burden and trends in human papillomavirus(HPV)-associated cancers and HPV vaccination coverage levels. JNCI,2013,djs491doi:10.1093/jnci/djs491.
[48]Jensen OM,Parkin DM,MacLennan R,et al. Cancer Registration:Principles and Methods. IARC Scientific Publications No. 95. IARC Lyon,France,1991.
[49]Kohler BA,Ward E,McCarthy BJ,et al. Annual report to the nation on the status of cancer,1975-2007,featuring tumors of the brain and other nervous system. J Natl Cancer Inst,2011,103:714-736.
[50]Levi F,Lucchini F,Negri E,et al. Continuing declines in cancer mortality in the European Union. Ann Oncol,2007,18:593-595.
[51]Lippman SM,Levin B. Cancer Prevention:Strong Science and Real Medicine. An overview. J Clinical Oncology,2005,23(2):249-253.
[52]Major A,Stewart SL. Celebrating 10 years of the National Comprehensive Cancer Control Program,1998 to 2008. Prev Chronic Dis,2009,6(4):A133.
[53]Mathers CD and Loncar D. Projections of global mortality and burden of disease from 2002 to 2030. PLoS Med,2006,3:e442.
[54]Moyer V,LeFevre M and Siu A. High-Priority Evidence Gaps for Clinical Preventive Services. Third Anual Report to Congress from the U. S. Preventive Services Task Force. 2013. U. S. Preventive Services Task Force. http:/ /www. uspreventiveservicestaskforce. org/annlrpt3/index. html.
[55]National Cancer Institute:The NCI Strategic Plan for Leading the Nation to Eliminate the Suffering and Death Due to Cancer. National Cancer Institute,U. S. Department of Health and Human Services,2006,NIH Publication No. 06-5773.
[56]Omran AR. The epidemiologic transition. A theory of the epidemiology of population change. Milbank Mem Fund Q,49:509-538,1971. http:/ /dx. doi. org/10.2307/3349375 PMID:5155251.
[57]Parkin DM,Ferlay J,Curado MP,et al. Fifty years of cancer incidence:CI5 I-IX. Int J Cancer,2010,127:2918-2927.
[58]Parkin DM. The evolution of the population-based cancer registry. Nat Rev Cancer,2006,6(8):603-12.
[59]Pirie K,Peto R,Reeves GK,et al. Million Women Study Collaborators:The 21st century hazards of smoking and benefits of stopping:a prospective study of one million women in the UK. Lancet,2013,381:133-141.
[60]Reynolds T. Preventive Oncology Recognizes 25 Years of Discoveries. J Natl Cancer Inst,2001,93(5):340-342.
[61]Rippe JM. Lifestyle Medicine:The Importance of Firm Grounding on Evidence. American J Lifestyle,2014,8(5):306-312.
[62]Rochester P,Chapel T,Black B,et al. The evaluation of comprehensive cancer control efforts:useful techniques and unique requirements. Cancer Causes Control,2005,16 Suppl 1:69-78.
[63]Rochester PW,Townsend JS,Given L,et al. Comprehensive cancer control:progress and accomplishments. Cancer Causes&Control,2010,(12):1967-1977.
[64]Rochester P,Adams E,Porterfield DS,et al. Cancer Plan Index:A Measure for Assessing the Quality of Cancer Plans. Journal of Public Health Management Practice,2011,17(6):E12-E17.
[65]Sanchez MA,Vinson CA,Porta ML,et al. Evolution of Cancer Control P. L. A. N. E. T.:moving research into practice. Cancer Causes Control,2012,23(7):1205-1212.
[66]Schottenfeld D and Beebe-Dimmer J. Alleviating the Burden of Cancer:A Perspective on Advances,Challenges,and Future Directions. Cancer Epidemiol Biomarkers Prev,2006,15(11):2049-2055.
[67]Stefanek ME,Andrykowski MA,Lerman C,et al. AACR Behavioral Science Task Force:Behavioral oncology and the war on cancer:partnering with biomedicine. Cancer Res,2009,69(18):7151-7156.
[68]Stewart BW and Wild CP(Eds):World Cancer Report 2014. IARC,Lyon,France,2014.
[69]Storm HH,Michelsen EV,Clemmensen IH,Pihl J. The Danish Cancer Registry—history,content,quality and use. Danish Medical Bulletin,1997,44(5):535-539.
[70]Sullivan R,Purushottham A. Towards an international cancer control plan:policy solutions for the global cancer epidemic. INCTR Magazine,2010,9:1-8.
[71]The Community Preventive Services Task Force. The 2013 Annual Report To Congress and to Agencies Related to the Work of the Task Force. CDC 2013 www. thecommunityguide. org.
[72]Thun M,Peto R,Boreham J,Lopez AD. Stages of the cigarette epidemic on entering its second century. Tob Control,2012,21:96-101.
[73]UICC. Supporting national cancer control planning:a toolkit for Civil Society Organisations(CSOS). UICC,Geneva,Switzerland,2012.
[74]United Nations. Political Declaration of the High-Level Meeting of the General Assembly on the Prevention and Control of Non-communicable Diseases. New York:United Nations. 2011 www. who. int/nmh/events/un_ ncd_summit2011/political_declaration_en. pdf.
[75]WHO. National Cancer Control Programmes. Policies and Managerial Guidelines,2nd ed. 2002 Available at http:/ /www. who. int/cancer/publications/nccp2002/en/index. html.
[76]WHO. MPOWER:A Policy Package to Reverse the Tobacco Epidemic. Geneva:WHO,2008. http:/ / www. who. int/tobacco/mpower/mpower_english. pdf.
[77]WHO. Global status report on noncommunicable diseases 2010. Geneva:WHO,2011. http:/ /www. who. int/chp/ncd_global_status_report/en.
[78]WHO. United Nations high-Level meeting on noncommunicable disease prevention and control. WHO,2011. http:/ /www. who. int/nmh/events/un_ncd_summit2011/en.
[79]WHO. Assessing National Capacity for the Prevention and Control of Noncommunicable Diseases:Report of the 2010 Global Survey. Geneva:WHO,2012. http:/ /www. who. int/chp/knowledge/national_prevention_ ncds/en.
[80]WHO. Global Action Plan for the Prevention and Control of Noncommunicable Diseases 2013-2020. Geneva:WHO,2013 http:/ /www. who. int/nmh/en/.
[81]WHO. WHO Report on the Global Tobacco Epidemic,2013:Enforcing Bans on Tobacco Advertising,Promotion and Sponsorship. Geneva:WHO,2013. http:/ /apps. who. int/iris/bitstream/10665/85380/ 1/9789241505871_eng. pdf.
[82]WHO. Guide for effective programmes-Module 1:Planning. Geneva:WHO,2006. http:/ /www. who. int/ cancer/publications/cancer_control_planning/en/index. html.
[83]WHO Secretariat. Cancer Prevention and Control. Report by the Secretariat to the 58th World Health Assembly. 2005 http:/ /www. who. int/gb/ebwha/pdf_files/WHA58/A58_16-en. pdf.
[84]WHO. WHO Statistical Information System(WHOSIS). http:/ /www. who. int/whosis.
[85]WHO. Global Status Report on Non-Communicable Diseases 2010. Geneva,WHO,2011. http:/ /www. who. int/nmh/publications/ncd_report2010/en.
[86]Wild CP. The role of cancer research in noncommunicable disease control. J Natl Cancer Inst,2012,104:1051-1058.
[87]World Cancer Research Fund/American Institute for Cancer Research. Food,Nutrition and the Prevention of Cancer:a Global Perspective. Washington,DC:AICR,1997.
[88]World Cancer Research Fund/American Institute for Cancer Research. Food,Nutrition,Physical Activity and the Prevention of Cancer:a Global Perspective. Washington,DC:AICR. 2007.
[89]World Health Organization and International Union Against Cancer. Global Action Against Cancer-Updated version. Geneva:WHO,UICC,2005.
[90]World Health Organization. WHO Framework Convention on Tobacco Control. Available from:http:/ / www. who. int/fctc/en.
[91]杨功焕,胡建平,饶克勤,等.中国死因登记与监测:历史、现况与挑战.北京:人民卫生出版社,2005.
[92]杨功焕,Huang ZJ,Tan J. Priorities of disease control in China—analysis on mortality data of National Disease Surveillance Points System.中华流行病学杂志,1996,17:199-202.
[93]Yu W. National Disease Monitoring System 2010:Data Set of Death Causes.北京:军事医学科学出版社,2012.